Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MDLZ vs CPB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MDLZ
Mondelez International, Inc.

Food Confectioners

Consumer DefensiveNASDAQ • US
Market Cap$79.42B
5Y Perf.+18.7%
CPB
Campbell Soup Company

Packaged Foods

Consumer DefensiveNASDAQ • US
Market Cap$6.25B
5Y Perf.-58.9%

MDLZ vs CPB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MDLZ logoMDLZ
CPB logoCPB
IndustryFood ConfectionersPackaged Foods
Market Cap$79.42B$6.25B
Revenue (TTM)$39.30B$10.04B
Net Income (TTM)$2.61B$550M
Gross Margin28.8%29.3%
Operating Margin9.4%12.1%
Forward P/E20.2x9.6x
Total Debt$22.40B$7.21B
Cash & Equiv.$2.13B$132M

MDLZ vs CPBLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MDLZ
CPB
StockMay 20May 26Return
Mondelez Internatio… (MDLZ)100118.7+18.7%
Campbell Soup Compa… (CPB)10041.1-58.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: MDLZ vs CPB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDLZ leads in 5 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Campbell Soup Company is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
MDLZ
Mondelez International, Inc.
The Long-Run Compounder

MDLZ carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 71.0% 10Y total return vs CPB's -44.5%
  • Lower volatility, beta 0.06, Low D/E 86.5%, current ratio 0.59x
  • 6.6% margin vs CPB's 5.5%
Best for: long-term compounding and sleep-well-at-night
CPB
Campbell Soup Company
The Income Pick

CPB is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 1 yrs, beta -0.02, yield 7.3%
  • Rev growth 6.4%, EPS growth 6.3%, 3Y rev CAGR 6.2%
  • Beta -0.02, yield 7.3%, current ratio 0.77x
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCPB logoCPB6.4% revenue growth vs MDLZ's 5.8%
ValueCPB logoCPBLower P/E (9.6x vs 20.2x)
Quality / MarginsMDLZ logoMDLZ6.6% margin vs CPB's 5.5%
Stability / SafetyMDLZ logoMDLZLower D/E ratio (86.5% vs 184.7%)
DividendsMDLZ logoMDLZ3.1% yield, 12-year raise streak, vs CPB's 7.3%
Momentum (1Y)MDLZ logoMDLZ-5.4% vs CPB's -36.6%
Efficiency (ROA)MDLZ logoMDLZ3.7% ROA vs CPB's 3.7%, ROIC 6.0% vs 9.1%

MDLZ vs CPB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MDLZMondelez International, Inc.
FY 2025
Biscuits
47.7%$18.4B
Chocolate
32.9%$12.7B
Gum and Candy
10.5%$4.1B
Cheese and Grocery
6.2%$2.4B
Beverages
2.6%$1.0B
CPBCampbell Soup Company
FY 2025
Baked Snacks
43.2%$4.4B
Beverages
29.7%$3.0B
Soups
27.1%$2.8B

MDLZ vs CPB — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCPBLAGGINGMDLZ

Income & Cash Flow (Last 12 Months)

Evenly matched — MDLZ and CPB each lead in 3 of 6 comparable metrics.

MDLZ is the larger business by revenue, generating $39.3B annually — 3.9x CPB's $10.0B. Profitability is closely matched — net margins range from 6.6% (MDLZ) to 5.5% (CPB). On growth, MDLZ holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMDLZ logoMDLZMondelez Internat…CPB logoCPBCampbell Soup Com…
RevenueTrailing 12 months$39.3B$10.0B
EBITDAEarnings before interest/tax$4.9B$1.6B
Net IncomeAfter-tax profit$2.6B$550M
Free Cash FlowCash after capex$2.6B$919M
Gross MarginGross profit ÷ Revenue+28.8%+29.3%
Operating MarginEBIT ÷ Revenue+9.4%+12.1%
Net MarginNet income ÷ Revenue+6.6%+5.5%
FCF MarginFCF ÷ Revenue+6.6%+9.2%
Rev. Growth (YoY)Latest quarter vs prior year+8.2%-4.5%
EPS Growth (YoY)Latest quarter vs prior year+38.7%-17.2%
Evenly matched — MDLZ and CPB each lead in 3 of 6 comparable metrics.

Valuation Metrics

CPB leads this category, winning 6 of 6 comparable metrics.

At 10.4x trailing earnings, CPB trades at a 68% valuation discount to MDLZ's 32.7x P/E. On an enterprise value basis, CPB's 7.5x EV/EBITDA is more attractive than MDLZ's 20.0x.

MetricMDLZ logoMDLZMondelez Internat…CPB logoCPBCampbell Soup Com…
Market CapShares × price$79.4B$6.2B
Enterprise ValueMkt cap + debt − cash$99.7B$13.3B
Trailing P/EPrice ÷ TTM EPS32.74x10.43x
Forward P/EPrice ÷ next-FY EPS est.20.24x9.60x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple20.03x7.46x
Price / SalesMarket cap ÷ Revenue2.06x0.61x
Price / BookPrice ÷ Book value/share3.10x1.61x
Price / FCFMarket cap ÷ FCF24.55x8.86x
CPB leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

CPB leads this category, winning 6 of 9 comparable metrics.

CPB delivers a 14.0% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $10 for MDLZ. MDLZ carries lower financial leverage with a 0.87x debt-to-equity ratio, signaling a more conservative balance sheet compared to CPB's 1.85x. On the Piotroski fundamental quality scale (0–9), CPB scores 7/9 vs MDLZ's 5/9, reflecting strong financial health.

MetricMDLZ logoMDLZMondelez Internat…CPB logoCPBCampbell Soup Com…
ROE (TTM)Return on equity+10.0%+14.0%
ROA (TTM)Return on assets+3.7%+3.7%
ROICReturn on invested capital+6.0%+9.1%
ROCEReturn on capital employed+7.3%+11.4%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.87x1.85x
Net DebtTotal debt minus cash$20.3B$7.1B
Cash & Equiv.Liquid assets$2.1B$132M
Total DebtShort + long-term debt$22.4B$7.2B
Interest CoverageEBIT ÷ Interest expense10.01x3.14x
CPB leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MDLZ leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MDLZ five years ago would be worth $11,375 today (with dividends reinvested), compared to $5,717 for CPB. Over the past 12 months, MDLZ leads with a -5.4% total return vs CPB's -36.6%. The 3-year compound annual growth rate (CAGR) favors MDLZ at -4.8% vs CPB's -22.3% — a key indicator of consistent wealth creation.

MetricMDLZ logoMDLZMondelez Internat…CPB logoCPBCampbell Soup Com…
YTD ReturnYear-to-date+16.3%-21.5%
1-Year ReturnPast 12 months-5.4%-36.6%
3-Year ReturnCumulative with dividends-13.8%-53.1%
5-Year ReturnCumulative with dividends+13.7%-42.8%
10-Year ReturnCumulative with dividends+71.0%-44.5%
CAGR (3Y)Annualised 3-year return-4.8%-22.3%
MDLZ leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MDLZ and CPB each lead in 1 of 2 comparable metrics.

CPB is the less volatile stock with a -0.02 beta — it tends to amplify market swings less than MDLZ's 0.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MDLZ currently trades 87.0% from its 52-week high vs CPB's 58.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMDLZ logoMDLZMondelez Internat…CPB logoCPBCampbell Soup Com…
Beta (5Y)Sensitivity to S&P 5000.06x-0.02x
52-Week HighHighest price in past year$71.15$36.16
52-Week LowLowest price in past year$51.20$19.76
% of 52W HighCurrent price vs 52-week peak+87.0%+58.0%
RSI (14)Momentum oscillator 0–10066.745.9
Avg Volume (50D)Average daily shares traded9.0M9.2M
Evenly matched — MDLZ and CPB each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — MDLZ and CPB each lead in 1 of 2 comparable metrics.

Wall Street rates MDLZ as "Buy" and CPB as "Hold". Consensus price targets imply 23.2% upside for CPB (target: $26) vs 8.3% for MDLZ (target: $67). For income investors, CPB offers the higher dividend yield at 7.30% vs MDLZ's 3.10%.

MetricMDLZ logoMDLZMondelez Internat…CPB logoCPBCampbell Soup Com…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$67.00$25.83
# AnalystsCovering analysts4129
Dividend YieldAnnual dividend ÷ price+3.1%+7.3%
Dividend StreakConsecutive years of raises121
Dividend / ShareAnnual DPS$1.92$1.53
Buyback YieldShare repurchases ÷ mkt cap+3.0%+1.0%
Evenly matched — MDLZ and CPB each lead in 1 of 2 comparable metrics.
Key Takeaway

CPB leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). MDLZ leads in 1 (Total Returns). 3 tied.

Best OverallCampbell Soup Company (CPB)Leads 2 of 6 categories
Loading custom metrics...

MDLZ vs CPB: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is MDLZ or CPB a better buy right now?

For growth investors, Campbell Soup Company (CPB) is the stronger pick with 6.

4% revenue growth year-over-year, versus 5. 8% for Mondelez International, Inc. (MDLZ). Campbell Soup Company (CPB) offers the better valuation at 10. 4x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Mondelez International, Inc. (MDLZ) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MDLZ or CPB?

On trailing P/E, Campbell Soup Company (CPB) is the cheapest at 10.

4x versus Mondelez International, Inc. at 32. 7x. On forward P/E, Campbell Soup Company is actually cheaper at 9. 6x.

03

Which is the better long-term investment — MDLZ or CPB?

Over the past 5 years, Mondelez International, Inc.

(MDLZ) delivered a total return of +13. 7%, compared to -42. 8% for Campbell Soup Company (CPB). Over 10 years, the gap is even starker: MDLZ returned +71. 0% versus CPB's -44. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MDLZ or CPB?

By beta (market sensitivity over 5 years), Campbell Soup Company (CPB) is the lower-risk stock at -0.

02β versus Mondelez International, Inc. 's 0. 06β — meaning MDLZ is approximately -434% more volatile than CPB relative to the S&P 500. On balance sheet safety, Mondelez International, Inc. (MDLZ) carries a lower debt/equity ratio of 87% versus 185% for Campbell Soup Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — MDLZ or CPB?

By revenue growth (latest reported year), Campbell Soup Company (CPB) is pulling ahead at 6.

4% versus 5. 8% for Mondelez International, Inc. (MDLZ). On earnings-per-share growth, the picture is similar: Campbell Soup Company grew EPS 6. 3% year-over-year, compared to -44. 7% for Mondelez International, Inc.. Over a 3-year CAGR, MDLZ leads at 7. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MDLZ or CPB?

Mondelez International, Inc.

(MDLZ) is the more profitable company, earning 6. 4% net margin versus 5. 9% for Campbell Soup Company — meaning it keeps 6. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CPB leads at 13. 2% versus 9. 4% for MDLZ. At the gross margin level — before operating expenses — CPB leads at 30. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MDLZ or CPB more undervalued right now?

On forward earnings alone, Campbell Soup Company (CPB) trades at 9.

6x forward P/E versus 20. 2x for Mondelez International, Inc. — 10. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CPB: 23. 2% to $25. 83.

08

Which pays a better dividend — MDLZ or CPB?

All stocks in this comparison pay dividends.

Campbell Soup Company (CPB) offers the highest yield at 7. 3%, versus 3. 1% for Mondelez International, Inc. (MDLZ).

09

Is MDLZ or CPB better for a retirement portfolio?

For long-horizon retirement investors, Mondelez International, Inc.

(MDLZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 06), 3. 1% yield). Both have compounded well over 10 years (MDLZ: +71. 0%, CPB: -44. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MDLZ and CPB?

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: MDLZ is a mid-cap income-oriented stock; CPB is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MDLZ

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

CPB

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 2.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MDLZ and CPB on the metrics below

Revenue Growth>
%
(MDLZ: 8.2% · CPB: -4.5%)
Net Margin>
%
(MDLZ: 6.6% · CPB: 5.5%)
P/E Ratio<
x
(MDLZ: 32.7x · CPB: 10.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.